BioNTech SE (BNTX) Current Leases (2021 - 2026)

BioNTech SE has reported Current Leases for 5 years, with the latest figure at $52.4 million in Q4 2025.

• Quarterly Current Leases rose 24.1% year-over-year to $52.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.4 million (up 24.1% YoY) and the FY2025 annual result came in at $50.8 million, up 20.45% from the prior year.
• Current Leases climbed to $52.4 million in Q4 2025 per BNTX's latest filing, from $42.2 million in the prior quarter.
• Over five years, Current Leases peaked at $52.4 million in Q4 2025 and troughed at $30.2 million in Q4 2023.
• A 5-year average of $38.7 million and a median of $36.7 million in 2022 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2024: Current Leases declined 17.68% in 2023, then surged 39.61% in 2024.
• Over 5 years, Current Leases stood at $31.9 million in 2021, then climbed by 15.08% to $36.7 million in 2022, then slipped by 17.68% to $30.2 million in 2023, then jumped by 39.61% to $42.2 million in 2024, then rose by 24.1% to $52.4 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $52.4 million, $42.2 million, and $30.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.